208 related articles for article (PubMed ID: 29465000)
21. The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2.
Yang X; Wang L; Li R; Zhao Y; Gu Y; Liu S; Cheng T; Huang K; Yuan Y; Song D; Gao S
Biochem Biophys Res Commun; 2018 Jul; 502(2):262-268. PubMed ID: 29803673
[TBL] [Abstract][Full Text] [Related]
22. miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines.
Zheng Y; Zhu C; Ma L; Shao P; Qin C; Li P; Cao Q; Ju X; Cheng G; Zhu Q; Gu X; Hua L
Urol Int; 2017; 98(1):102-110. PubMed ID: 27074041
[TBL] [Abstract][Full Text] [Related]
23. Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.
Yu Z; Zhao H; Feng X; Li H; Qiu C; Yi X; Tang H; Zhang J
Mol Ther Nucleic Acids; 2019 Sep; 17():516-529. PubMed ID: 31351327
[TBL] [Abstract][Full Text] [Related]
24. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.
Zhuang M; Gao W; Xu J; Wang P; Shu Y
Biochem Biophys Res Commun; 2014 Jun; 448(3):315-22. PubMed ID: 24388988
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-425-5p promotes the development of prostate cancer via targeting forkhead box J3.
Zhang JY; Su XP; Li YN; Guo YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):547-554. PubMed ID: 30720162
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer.
Liu L; Yang J; Zhu X; Li D; Lv Z; Zhang X
FEBS J; 2016 Jun; 283(12):2326-39. PubMed ID: 27093644
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma.
Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J
Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956
[TBL] [Abstract][Full Text] [Related]
28. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
29. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
[TBL] [Abstract][Full Text] [Related]
30. Silencing H19 regulated proliferation, invasion, and autophagy in the placenta by targeting miR-18a-5p.
Zhang L; Deng X; Shi X; Dong X
J Cell Biochem; 2019 Jun; 120(6):9006-9015. PubMed ID: 30536700
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma.
Zhang D; Cao J; Zhong Q; Zeng L; Cai C; Lei L; Zhang W; Liu F
Biomed Pharmacother; 2017 Nov; 95():1187-1193. PubMed ID: 28931210
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions.
Ichihara A; Wang Z; Jinnin M; Izuno Y; Shimozono N; Yamane K; Fujisawa A; Moriya C; Fukushima S; Inoue Y; Ihn H
J Allergy Clin Immunol; 2014 Apr; 133(4):1065-74. PubMed ID: 24184144
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
[TBL] [Abstract][Full Text] [Related]
34. MiR-18a-5p Promotes Proliferation, Migration, and Invasion of Endometrial Cancer Cells by Targeting THBD.
Dong H; Li Y; Zhou J; Song J
Crit Rev Eukaryot Gene Expr; 2021; 31(2):63-73. PubMed ID: 34347980
[TBL] [Abstract][Full Text] [Related]
35. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
36. MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5.
Xing Q; Xie H; Zhu B; Sun Z; Huang Y
Biomed Res Int; 2019; 2019():6394784. PubMed ID: 31111062
[TBL] [Abstract][Full Text] [Related]
37. Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR.
Liu T; Chi H; Chen J; Chen C; Huang Y; Xi H; Xue J; Si Y
Gene; 2017 Oct; 631():29-38. PubMed ID: 28843521
[TBL] [Abstract][Full Text] [Related]
38. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C
Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
Zhang R; Xia T
Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.
Ozen M; Karatas OF; Gulluoglu S; Bayrak OF; Sevli S; Guzel E; Ekici ID; Caskurlu T; Solak M; Creighton CJ; Ittmann M
Cancer Invest; 2015 Jul; 33(6):251-8. PubMed ID: 25951106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
